Pascal d’Azemar

2.0k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

Pascal d’Azemar is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Pascal d’Azemar has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 6 papers in Surgery. Recurrent topics in Pascal d’Azemar's work include Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Pascal d’Azemar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Pascal d’Azemar collaborates with scholars based in France, Netherlands and Italy. Pascal d’Azemar's co-authors include Luc Sagnard, Gérald Simonneau, Martin H. Prins, Alexander Gallus, A.G.M. van den Belt, Colin Chesterman, Maria M.W. Koopman, Harry R. Büller, Desiderius P.M. Brandjes and Paul Ockelford and has published in prestigious journals such as New England Journal of Medicine, Circulation and Thrombosis and Haemostasis.

In The Last Decade

Pascal d’Azemar

11 papers receiving 1.4k citations

Hit Papers

Treatment of Venous Thrombosis with Intravenous Unfractio... 1996 2026 2006 2016 1996 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
    1996 810 citations Maria M.W. Koopman, Paolo Prandoni et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal d’Azemar France 9 1.3k 972 578 259 237 13 1.5k
Michel Samama France 6 1.4k 1.0× 927 1.0× 615 1.1× 304 1.2× 343 1.4× 11 1.6k
Russel Hull Canada 10 1.5k 1.2× 1.1k 1.2× 508 0.9× 299 1.2× 330 1.4× 16 1.8k
Jacques R. Leclerc Canada 16 1.4k 1.1× 1.0k 1.0× 682 1.2× 177 0.7× 306 1.3× 24 1.8k
William Brien Canada 11 833 0.6× 646 0.7× 410 0.7× 147 0.6× 252 1.1× 19 1.2k
Antoine Élias France 20 1.2k 0.9× 761 0.8× 465 0.8× 289 1.1× 278 1.2× 58 1.5k
Yves Page United States 4 1.7k 1.3× 1.0k 1.0× 682 1.2× 618 2.4× 227 1.0× 7 1.8k
Marica Perlati Italy 5 799 0.6× 486 0.5× 256 0.4× 139 0.5× 137 0.6× 6 972
Cathy Emery United States 9 856 0.7× 529 0.5× 286 0.5× 219 0.8× 181 0.8× 11 936
Russell D. Hull Canada 14 1.2k 0.9× 725 0.7× 474 0.8× 163 0.6× 187 0.8× 22 1.3k
S Törngren Sweden 20 732 0.6× 505 0.5× 528 0.9× 193 0.7× 185 0.8× 49 1.3k

Countries citing papers authored by Pascal d’Azemar

Since Specialization
Citations

This map shows the geographic impact of Pascal d’Azemar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal d’Azemar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal d’Azemar more than expected).

Fields of papers citing papers by Pascal d’Azemar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal d’Azemar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal d’Azemar. The network helps show where Pascal d’Azemar may publish in the future.

Co-authorship network of co-authors of Pascal d’Azemar

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal d’Azemar. A scholar is included among the top collaborators of Pascal d’Azemar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal d’Azemar. Pascal d’Azemar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mahé, Isabelle, et al.. (2005). Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study. European Journal of Clinical Pharmacology. 61(5-6). 347–351. 58 indexed citations
2.
Meignan, Michel, Jean Rosso, Hélène Gauthier, et al.. (2000). Systematic Lung Scans Reveal a High Frequency of Silent Pulmonary Embolism in Patients With Proximal Deep Venous Thrombosis. Archives of Internal Medicine. 160(2). 159–159. 169 indexed citations
3.
Mismetti, Patrick, S Laporte‐Simitsidis, Christelle Navarro, et al.. (1998). Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin). Thrombosis and Haemostasis. 79(6). 1162–1165. 78 indexed citations
4.
Charbonnier, B, et al.. (1998). Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis. Thrombosis and Haemostasis. 79(5). 897–901. 72 indexed citations
5.
Lablanche, Jean‐Marc, Eugène McFadden, Nicolas Piriou, et al.. (1997). Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty. Circulation. 96(10). 3396–3402. 34 indexed citations
6.
Koopman, Maria M.W., Paolo Prandoni, Franco Piovella, et al.. (1996). Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home. New England Journal of Medicine. 334(11). 682–687. 810 indexed citations breakdown →
7.
Nurmohamed, Michael T., C M A Henkens, Mmw Koopman, et al.. (1996). Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery. Thrombosis and Haemostasis. 75(2). 233–238. 187 indexed citations
8.
9.
10.
Rostin, M, et al.. (1990). Pharmacodynamics of CY 216 in healthy volunteers: inter‐individual variations. Fundamental and Clinical Pharmacology. 4(1). 17–23. 8 indexed citations
11.
12.
Steinbach, Gerald, et al.. (1990). [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].. PubMed. 11(1). 17–21. 5 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Samama Breakdown of academic impact, for papers by Russel Hull Breakdown of academic impact, for papers by Jacques R. Leclerc Breakdown of academic impact, for papers by William Brien Breakdown of academic impact, for papers by Antoine Élias Breakdown of academic impact, for papers by Yves Page Breakdown of academic impact, for papers by Marica Perlati Breakdown of academic impact, for papers by Cathy Emery Breakdown of academic impact, for papers by Russell D. Hull Breakdown of academic impact, for papers by S Törngren
Rankless by CCL
2026